ESPGHAN Young Investigator Forum

Another YIF meeting is coming up!

The ESPGHAN Young Investigators Forum (YIF) has been an integral part of the society for the last 21 years.  The meeting was established to nurture academic development in the society and foster collaborations amongst the emerging generations of academics and clinicians. Over the years YIF has seen many individuals, their juniors and team members come through to become established academics and clinicians as well as develop friendships and collaborations across Europe.

Young Investigator's Forum (YIF). An intensive 3 day meeting run once a year that includes (i) ice-breaking sessions; (ii) delegate presentations and detailed feedback on generic (abstract, presentation etc) and project specific items; (iii) faculty presentations (abstract writing, presentation and feedback skills, manuscript preparation, preparation for an academic career) and (iv) an interactive social programme. The forum is residential and restricted to 20 delegates chosen following a competitive application and selection process. For the last 5 years the meeting has been held in the Netherlands (Bergen) in late September. Dates for 2018 are 26th-29th September 2018.

Aim of the YIF meeting and social gathering

    To provide young investigators with a friendly and constructive atmosphere in order to present their research and learn from each other.
    To allow the development of key skills in presenting, writing abstracts and papers as well as to gain insight into an academic career.
    To meet and network with other delegates and senior faculty members and to set up research collaborations in Europe.
    To enable young investigators to contribute to the scientific development of ESPGHAN.

Definition of a Young Investigator
Active clinical or laboratory based researcher working in paediatric gastroenterology, hepatology and nutrition. Ideally with less than 10 years training experience.

Applications should include:

    Letter of support from an ESPGHAN member
    Short CV (maximum 2 pages A4)
    Abstracts must have title, author(s) and institution(s) where the work was done and be written as per instructions below.
    A completed application form

Please Note: Delegates may not attend for more than one forum
Travel and accommodation expenses will be covered by an unrestricted educational grant

Abstract Instructions

    Abstracts must contain data and meet international ethical standards.
    Abbreviations should be defined.
    Trade names cannot be mentioned in the title. However, trade names in brackets will be accepted in the body of the text.
    The abstract cannot contain more than 3,000 characters (approx.450 words) (including blank spaces, punctuation as well as authors affiliation and titles).
    The abstract must be structured into the following sections:
       - Aims and Objectives
       - Methods
       - Results
       - Conclusion
    One table can be included, with the following restrictions:
   - Max number of columns: 10
   - Max number of rows: 10
Please note that tables may significantly reduce the number of available characters.


Cost & Registration

ESPGHAN will cover  for each accepted delegated:
   •    accommodation
   •    three meals per day
   •    course materials
   •    Social programme

We offer for each delegate that was accepted a travel refund up to 400 EUR.


LOCATION

BLOOMING HOTEL
Duinweg 5     
1861 GL Bergen
The Netherlands
 Please find more Information’s on the Hotel Homepage:  http://www.blooming-hotels.com/default-en.html 

Programme


Wednesday 26st September 2018:
12.00 – 14.00 Transport Airport Amsterdam – Blooming Hotel Bergen

14.00 – 16.00 Faculty members Meeting

Programme
Chairs:  Iva Hojsak, Florence Lacaille, Jernej Dolinsek.
16.00 – 16.05 Welcome by faculty
16.05 – 17.25 Interactive Introduction with the delegates
17.25 – 17.50 Faculty state of the Art lecture: Jernej Dolinsek Principles of feedback

17.50 - 18.00 Break

18.00 – 19.00 Group Work (Ice breaker)
19.00 – 19.30 Faculty state of the Art lecture: Iva Hojsak Presentation techniques

19.30 Break


19.45 Pre dinner drinks + Dinner at hotel
      
Thursday 27th September

Chair:
09.00 – 09.30 Delegate 1. delegate abstract title (comment x/y/faculty)
09.30 – 10.00 Delegate 2:
 delegate abstract title (comment x/y/faculty)
10.00 – 10.30 Faculty state of the Art lecture: 
How to be an efficient researcher - Developing proposals and writing grant applications
10.30 – 11.00 coffee break / Photo
11.00 – 11.30 Delegate 3:
 delegate abstract title (comment x/y/faculty)
11.30 – 12.00 Delegate 4:
 delegate abstract title (comment x/y/faculty)
12.00 – 12.30 Delegate 5:
 delegate abstract title (comment x/y/faculty)

12.30 – 13.30 Lunch Break

Chair: Iva Hojsak
13.30 – 14.00 Delegate 6:
 delegate abstract title (comment x/y/faculty)
14.00 – 14.30 Delegate 7:
 delegate abstract title (comment x/y/faculty)
14.30 – 15.00 Delegate 8:
 delegate abstract title (comment x/y/faculty)
15.00 – 15.30 Coffee/tea break
15.30 – 16.00 Delegate 9:
 delegate abstract title (comment x/y/faculty)
16.00 – 16.30 Delegate 10:
 delegate abstract title (comment x/y/faculty)
16.30 break
(or add delegate)

17.30 Depart from the hotel for evening event and dinner 

Friday 28th September
Chair: Florence Lacaille
09.00 – 09.30 Delegate 11/12:
 delegate abstract title (comment x/y/faculty)
09.30 – 10.00 Delegate 12/13:
 delegate abstract title (comment x/y/faculty)
10.00 – 10.30 Delegate 13/14:
 delegate abstract title (comment x/y/faculty)
10.30 – 11.00 Coffee break
11.00 – 11.30 Delegate 14/15:
 delegate abstract title (comment x/y/faculty)
11.30 – 12.00 Delegate 15/16:
 delegate abstract title (comment x/y/faculty)
12.00 – 12.30 Delegate 16/17:
 delegate abstract title (comment x/y/faculty)
12.30 – 13.00 Faculty state of the Art lecture: Florence Lacaille Writing a scientific publication

13.00 – 14.00 Lunch

Chair: Jernej Dolinsek
14.00 – 14.30 Delegate 17/18:
 delegate abstract title (comment x/y/faculty)
14.30 – 15.00 Delegate 18/19:
 delegate abstract title (comment x/y/faculty)
15.00 – 15.30 Delegate 19/20:
 delegate abstract title (comment x/y/faculty)
15.30 – 16.15 Tea / Break (Faculty collation of scores)
16.15 – 16.45 Closing evaluation

17.00 Depart from the hotel for evening event and farewell dinner
   
 
Saturday 29th September 2018
 
Breakfast and check out
Transfer back to Amsterdam Airport

Florence Lacaille
AFFILIATION: Hepatogastroenterology-Nutrition Unit,
Hôpital Necker-Enfants malades, Paris
COUNTRY: France

Florence Lacaille is pediatric hepatologist, also responsible for intestinal transplantation in Necker-Enfants malades (second largest hepatology unit in France and first intestinal transplantation unit in Europe).


Member of ESPGHAN since the last century, previous member of the ESPGHAN Council and the Hepatology Committee. Doing her best to help young active enthousiastic doctors to feel attracted to ESPGHAN, because of all the opportunities (clinical
work, research, networking, education...) the Society offers.

Iva Hojsak
AFFILIATION: Referral Center for Pediatric Gastroenterology and Nutrition
Children’s Hospital Zagreb
COUNTRY: Croatia


Iva Hojsak, MD, PhD is pediatric gastroenterologist and head of the Referral Center for Pediatric Gastroenterology and Nutrition, Children’s Hospital Zagreb, Croatia. She graduated on Medical School of Zagreb, where she also received her PhD degree. She has published more
than 90 scientific and clinical papers and has been a coworker in more than 15 international and Croatian scientific projects. She is a head of Scientific Committee of the Children’s Hospital Zagreb, secretary of the ESPGHAN Committee on Nutrition and associate editor of Journal of Pediatric Gastroenterology and Nutrition. Her main clinical/research interests include probiotics, intestinal failure and parenteral
nutrition and inflammatory bowel disease.

Jernej Dolinsek
AFFILIATION: University Medical Centre Maribor, Maribor, Slovenia
COUNTRY: Slovenia

Jernej Dolinšek works at the Gastroenterology Unit of Paediatric Department University Medical Centre Maribor, Slovenia, where he started to work in 1996. He serves as a head of the unit since 2012. He served as a head of the Department of Paediatrics in 2010-2012.
During his training, he has spent valuable time in Tampere, Finland with the research group of Prof. Markku Mäki. Based on this work he has finished his PhD aimed at the study of apoptotic processes in celiac disease.
He has been actively collaborating in several national and international study groups and projects in the field of paediatric gastroenterology mainly focusing on celiac disease. Currently he is actively involved in Focus-In-CD, Medicel, ProCeDE, EuroPaedHP projects and initiatives.
He has been invited as a guest speaker to many international events, especially in Eastern European countries. He has been president of Slovene Celiac Disease Society for one mandate and is still a member of Executive board. He is a member of Slovene Medical Chamber Council, Slovene Paediatric Association Executive Board.
In 1997, he was a chair of International Celiac Disease Symposium in Maribor.
At the time, he serves in ESPGHAN Council as ESPGHAN International Affairs Representative (2014-2017); he is a member of UEG Council, and member of ESPGHAN YIF faculty. Within ESPGHAN, he is a member of coeliac disease Special Interest Group.
He is happily married and has two wonderful children.

Amit Assa

AFFILIATION: Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Hospital of Israel.

COUNTRY: Israel

Amit Assa, M.D, M.H.A 

Professor of Pediatrics and Head of IBD program. The Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Hospital of Israel. Member of the ESPGHAN Porto IBD working group. 

Fellowship in pediatric gastroenterology at the Department for Gastroenterology, Hospital for Sick Children, Toronto, Canada. 

Master in Health Administration, Beer Sheva University. 

Professor of Pediatrics, The Sackler Faculty of Medicine, Tel-Aviv University 

Published over 60 papers in peer-review journals. Main research focus is on IBD epidemiology, long-term outcomes and specifically on pharmacokinetics of biologic agents including leading several interventional RCTs currently active.